Methods and compounds for influencing beta3-integrin-dependent intracellular processes

摘要

The invention relates to the use of beta3-endonexin-long or beta3-endonexin-short for finding active substances for the treatment of arteriosclerosis, unstable plaques resulting from the latter, acute coronary thrombosis, cardiac infarct, stroke, peripheral arterial occlusion diseases, chronic venous ulcer and restenosing processes.